Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • bladder (2)
  • female (1)
  • gait (3)
  • humans (1)
  • impairment (2)
  • motion (1)
  • void (13)
  • walk (2)
  • Sizes of these terms reflect their relevance to your search.

    Lower urinary tract symptoms, especially overactive bladder, are frequent and disabling in individuals with multiple sclerosis (IwMS). An association with gait disorders is common, which could aggravate continence difficulties and affect quality of life. The association between the need to void and walking has never been studied in this population. The primary aim of this study was to assess the effect of a strong desire to void (SDV) on walking speed in IwMS and lower urinary tract symptoms. The secondary aim was to identify clinical or urodynamic factors associated with walking speed impairment at SDV in this population. We included IwMS with urinary disorders and Expanded Disability Status Scale score<7 in this observational study. Individuals underwent 3 10-m walk tests (10MWT) and one Timed Up and Go (TUG) test at SDV and at post-void (PV). Among the 72 IwMS included (mean [SD] age 50.6 [11.6] years; 46 [64%] females), the mean (SD) speed for 10MWT was 1.00 (0.31) m.s-1 at SDV and 1.07 (0.30) m.s-1 at PV (P<0.0001). Time for TUG was also increased when individuals felt SDV: mean 11.53 (4.6) sec at SDV versus 10.77 (3.8) sec at PV (P=0.004). No predictors of greater impairment of walking speed at SDV were identified. This study suggests a clinical impact of bladder sensation on walking speed in IwMS and urinary disorders. None of the individual characteristics could predict greater decrease in gait velocity at SDV. Copyright © 2020 Elsevier Masson SAS. All rights reserved.

    Citation

    Claire Hentzen, Nicolas Turmel, Camille Chesnel, Audrey Charlanes, Frédérique Le Breton, Samer Sheikh Ismaël, Gérard Amarenco. Effect of a strong desire to void on walking speed in individuals with multiple sclerosis and urinary disorders. Annals of physical and rehabilitation medicine. 2020 Mar;63(2):106-110

    Expand section icon Mesh Tags


    PMID: 31981839

    View Full Text